At a glance
This program funds rare cancers research ideas that are ready for development and could lead to high-impact findings, new discoveries, or better outcomes. Eligible applicants include extramural and intramural U.S. Department of War organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities; independent investigators at eligible organizations may serve as principal investigator. The program expects about 15 awards, with total costs capped at $490,000 per award and a maximum period of performance of 3 years. Cost sharing is not required. The research must involve cancers affecting six or fewer people per 100,000 per year in the United States, and clinical trials are not allowed.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features: The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research. Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study. Research should have high potential impact on rare cancers and the patient community.
Who can apply
- Unrestricted